Cleared Traditional

K131339 - CAPNOMASK

K131339 is an FDA 510(k) clearance for CAPNOMASK, manufactured by Mediplus , Ltd.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 200-day FDA review.

K131339 · Mediplus , Ltd. · Anesthesiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2013
Decision
200d
Days
Class 2
Risk

K131339 is an FDA 510(k) clearance for the CAPNOMASK. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Mediplus , Ltd. (Bonita Springs, US). The FDA issued a Cleared decision on November 25, 2013 after a review of 200 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K131339

510(k) Number K131339 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 2013
Decision Date November 25, 2013
Days to Decision 200 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d slower than avg
Panel avg: 140d · This submission: 200d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 266
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K131339.
O2 NASAL CANNULA WITH CO2 MONITORING
K140113 · Flexicare Medical, Ltd. · Mar 2014
CO2/O2 NASAL CANNULA (WITH 4 (10CM) O2 AND CO2 TUBE), CO2/O2 NASAL CANNULA (WITH 8 (240CM) O2 AND 4 (10CM) CO2 TUBE),
K131410 · Southmedic, Inc. · Jan 2014
M1 CAPNOGRAPHY MASK
K133806 · Monitor Mask, Inc. · Dec 2013
TG-970P SENSOR KIT W/ NEW AIRWAY ADAPTER (YG-213T)
K122214 · Nihon Kohden Corp. · May 2013
CAPNO MODULE, 92517
K130112 · Spacelabs Healthcare · Mar 2013
DISPOSABLE GAS SAMPLING LINE WITH AND WITHOUT IN-LINE FILTER
K122075 · Intersurgical, Inc. · Dec 2012